Snowden Capital Advisors »

Amicus Therapeutics shares owned by Snowden Capital Advisors

Quarter-by-quarter ownership of Amicus Therapeutics (FOLD) shares owned by Snowden Capital Advisors from 13F filings

Historical chart of Snowden Capital Advisors investment in Amicus Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Amicus Therapeutics held by Snowden Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Amicus Therapeutics by Snowden Capital Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $586k 50k 11.78
2023-12-31 $718k 51k 14.19
2023-09-30 $652k 54k 12.16
2023-06-30 $729k 58k 12.56
2023-03-31 $650k 59k 11.09
2022-12-31 $706k 58k 12.21
2022-09-30 $410k 39k 10.43
2022-06-30 $284k 27k 10.71